Pasar al contenido principal

MECANISMOS DE VIRULENCIA DE SEROTIPOS DE NEUMOCOCO EMERGENTES

PID2020-119298RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario INSTITUTO DE SALUD CARLOS III DE MADRID (ISCIII)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 8
Encontrada(s) 1 página(s)

Docta Complutense
Publicación Artículo científico (JournalArticle)

Combination of Cefditoren and N-acetyl-Cysteine Shows a Synergistic Effect against Multidrug-Resistant Streptococcus pneumoniae Biofilms

  • Llamosí, Mirella
  • Sempere, Julio
  • Coronel, Pilar
  • Gimeno, Mercedes
  • Yuste, Jose
  • Domenech, Mirian
Biofilm formation by Streptococcus pneumoniae is associated with colonization of the upper respiratory tract, including the carrier state, and with chronic respiratory infections in patients suffering from chronic obstructive pulmonary disease (COPD). The use of antibiotics alone to treat recalcitrant infections caused by biofilms is insufficient in many cases, requiring novel strategies based on a combination of antibiotics with other agents, including antibodies, enzybiotics, and antioxidants. In this work, we demonstrate that the third-generation oral cephalosporin cefditoren (CDN) and the antioxidant N-acetyl-l-cysteine (NAC) are synergistic against pneumococcal biofilms. Additionally, the combination of CDN and NAC resulted in the inhibition of bacterial growth (planktonic and biofilm cells) and destruction of the biofilm biomass. This marked antimicrobial effect was also observed in terms of viability in both inhibition (prevention) and disaggregation (treatment) assays. Moreover, the use of CDN and NAC reduced bacterial adhesion to human lung epithelial cells, confirming that this strategy of combining these two compounds is effective against resistant pneumococcal strains colonizing the lung epithelium. Finally, administration of CDN and NAC in mice suffering acute pneumococcal pneumonia caused by a multidrug-resistant strain was effective in clearing the bacteria from the respiratory tract in comparison to treatment with either compound alone. Overall, these results demonstrate that the combination of oral cephalosporins and antioxidants, such as CDN and NAC, respectively, is a promising strategy against respiratory biofilms caused by S. pneumoniae. IMPORTANCE Streptococcus pneumoniae is one of the deadliest bacterial pathogens, accounting for up to 2 million deaths annually prior to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Vaccines have decreased the burden of diseases produced by S. pneumoniae, but the rise of antibiotic-resistant strains and nonvaccine serotypes is worrisome. Pneumococcal biofilms are associated with chronic respiratory infections, and treatment is challenging, making the search for new antibiofilm therapies a priority as biofilms become resistant to traditional antibiotics. In this work, we used the combination of an antibiotic (CDN) and an antioxidant (NAC) to treat the pneumococcal biofilms of relevant clinical isolates. We demonstrated a synergy between CDN and NAC that inhibited and treated pneumococcal biofilms, impaired pneumococcal adherence to the lung epithelium, and treated pneumonia in a mouse pneumonia model. We propose the widely used cephalosporin CDN and the repurposed drug NAC as a new antibiofilm therapy against S. pneumoniae biofilms, including those formed by antibiotic-resistant clinical isolates.
Repisalud
Publicación Artículo científico (JournalArticle)

Evaluation of the hydrogels Matrigel, Biogelx, PLTMAx and GelMA in the generation of minilungs from human embryonic stem cells (hESC).

  • Chamorro-Herrero, Irene
  • Sempere, Julio
  • Yuste, Jose Enrique
  • Zambrano, Alberto
Organoids isolated from adult cells and, especially, those synthesized from human pluripotent stem cells, both induced (hiPSCs) or embryonic stem cells, (hESCs), offer unique opportunities for disease modeling, drug testing or organ replacement (regenerative medicine). The biofabrication of functional tissue require supportive biomaterials and scaffolds generated from reliable materials. Due to the murine origin of the market choice hydrogel (Matrigel), its suitability for regenerative medicine or clinical translation is greatly limited. Thus, the development of new supportive materials for long-term cell survival and differentiation of pluripotent stem cells which are biocompatible with clinical translation and automatized synthesis, or bioprinting, is an urgent need. In the present study, we have evaluated the suitability of four representative hydrogels, also fitting as bioinks, as supportive biomaterials for cell growth and differentiation of respiratory organoids or minilungs from hESCs. The hydrogels Biogelx, PLTMax and GelMA, were evaluated in the generation of minilungs in parallel to Matrigel. In contrast to those in Matrigel, the minilungs embedded into the hydrogels tested were smaller, less branched or fragmented. The minilungs showed the expression of three surfactant proteins, despite exhibiting abnormal structures. The aberrant cell growth and cellular arrangement observed suggest that these promising hydrogels or bioinks tested might not be biocompatible for organoid differentiation and for establishing future strategies based on automatized synthesis or bioprinting of lung tissue.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Surveillance of invasive pneumococcal disease in Spain exploring the impact of the COVID-19 pandemic (2019-2023)

  • Pérez-García, Covadonga
  • Sempere, Julio
  • de Miguel, Sara
  • Hita, Samantha
  • Úbeda, Aída
  • Vidal, Erick Joan
  • Llorente, Joaquín
  • Limia, Aurora
  • de Miguel, Angel Gil
  • Sanz, Juan Carlos
  • Martinón-Torres, Federico
  • Ardanuy, Carmen
  • Domenech, Mirian
  • Yuste, Jose
Dynamic trends of invasive pneumococcal disease (IPD) including the evolution of prevalent serotypes are very useful to evaluate the impact of current and future pneumococcal conjugate vaccines (PCVs) and the rise of non-vaccine serotypes. In this study, we include epidemiological patterns of S. pneumoniae before and after COVID-19 pandemic., This work was supported by Ministerio de Ciencia e Innovación (MICINN) [grant PID2020-119298RB-I00] and internal funding from ISCIII. This study was also partially funded by grants from Merck Sharp Dohme [grant MISP#IISP60170], although this funder had no intervention in the results of this study., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The rise of serotype 8 is associated with lineages and mutations in the capsular operon with different potential to produce invasive pneumococcal disease

  • Pérez-García, Covadonga
  • González-Díaz, Aida
  • Domenech, Mirian
  • Llamosí, Mireia
  • Úbeda, Aída
  • Sanz, Juan Carlos
  • García, Ernesto
  • Ardanuy, Carmen
  • Sempere, Julio
  • Yuste, José
Despite conjugate vaccine introduction to prevent invasive pneumococcal disease (IPD), serotype replacement by non-vaccine serotypes is a constant concern. In this study, we elucidate the rise of serotype 8 causing IPD in Spain. We evaluated isolates received during the period 2008–2023 including whole genome sequencing characterization and host–pathogen interaction studies. Serotype 8 has emerged as one of the most prevalent serotypes causing IPD in both children and adults. CC53/GPSC3 carrying pspC 6.11 was the dominant lineage in recent years, displaying increased adhesion to lung cells, enhanced biofilm formation, higher factor H recruitment, improved phagocytosis evasion, and greater virulence in a mice pneumonia model than other co-circulating lineages which could explain its predominance. Morphologically, serotype 8 strains exhibit two appearances on blood agar plates: mucoid colonies, and non-mucoid variants. Molecular characterization revealed that non-mucoid variants harbour mutations in the wchA gene and/or others within the capsular operon, leading to increased adhesion and biofilm formation, albeit with reduced immune evasion capacity. Serotype 8 has become a major cause of IPD, with CC53/GPSC3 as the dominant lineage due to its pathogenic advantages. The versatility of the capsular operon contributes to its success in causing IPD. The use of vaccines with broader coverage, such as PCV20 or PCV21, containing this serotype, may offer an effective strategy to ameliorate the impact on IPD by serotype 8., This work was supported by the Spanish Ministry of Science and Innovation (grant PID2020–119298RB-I00), by Instituto de Salud Carlos III (grant PI24CIII/00045) and partially funded by a private grant from MSD (MISP Call; MISP#IISP60170)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Upsurge of pneumococcal clade I-α/CC180 serotype 3 and its association with a LytA mutation linked to immune evasion and disease potential: an observational and experimental study

  • Pérez-García, Covadonga
  • Sempere, Julio
  • Llamosí, Mirella
  • González-Díaz, Aída
  • de Miguel, Sara
  • Vidal-Alcántara, Erick Joan
  • Sanz, Juan Carlos
  • García, Ernesto
  • Brueggemann, Angela B
  • Ardanuy, Carmen
  • Domenech, Mirian
  • Yuste, Jose
Background Streptococcus pneumoniae serotype 3 is one of the most prevalent serotypes that cause invasive pneumococcal disease (IPD) in children and adults worldwide. Serotype 3 is associated with vaccine failures and breakthrough episodes in children vaccinated with 13-valent pneumococcal conjugate vaccine (PCV13). In this study, we aimed to investigate potential genetic mechanisms that could explain the increase in cases of serotype 3 IPD in Spain. Methods We analysed the epidemiology of serotype 3 causing IPD in Spain, during 2009–23, in different age groups. Molecular characterisation was performed by whole-genome sequencing. Host–pathogen interactions of the different lineages were evaluated in terms of interaction with lung epithelial cells, biofilm formation, and capsular polysaccharide production, using opsonophagocytosis assays and mouse models of pneumonia. We used Poisson regression models to compare incidence and chi-square test calculations to identify clonal variations across vaccine periods. Findings Genomic analyses confirmed the predominance of clade I-α/clonal complex (CC) 180 in Spain, which shows increased resistance to complement-mediated immunity and phagocytosis and enhanced potential to infect lung cells. In all isolates of this lineage, we observed a single amino acid substitution (166His→Tyr) in the crucial virulence factor LytA, which increased its enzymatic activity. On evaluating the phagocytosis of mutants without LytA of the two major lineages of serotype 3 (CC180 and CC260), LytA was responsible for the increased phagocytosis-evasion pattern of clade I-α/CC180. Evaluation of individuals with IPD caused by different serotype 3 genotypes confirmed a significant (p < 0·05) association between cardiac and respiratory comorbidities and infection by sequence type 180/CC180, which showed the importance of CC180 in IPD. Interpretation Our findings confirm that PCV13 reduced IPD cases caused by the susceptible CC260 lineage until CC260 was replaced by the clade I-α/CC180 lineage, which has a higher potential to cause IPD and divert the host immune system. A key mutation on LytA protein was associated with this hypervirulent phenotype. Emerging lineages jeopardise the effectiveness of pneumococcal conjugate vaccines, This work was supported by Ministerio de Ciencia e Innovación (MICINN; PID2020-119298RB-I00 and PID2024-161570OB-I00) and an internal fund from Instituto de Salud Carlos III (ISCIII). CP-G was supported by a Formación del Profesorado Universitario fellowship from MICINN (FPU21/01798). This study was also funded in part by grants from MSD (MISP#IISP60170), although this funder had no intervention in the results of this study. PubMLST is supported by a Wellcome Trust Biomedical Resource Grant (218205/Z/19/Z), Peer reviewed, Modelo experimental alternativo-NAM, Organismos alternativos no vertebrados - Microorganismos Unicelulares - Bacterias
Docta Complutense
Publicación Artículo científico (JournalArticle)

Vaccination against Community-Acquired Pneumonia in Spanish Adults: Practical Recommendations by the NeumoExperts Prevention Group

  • Redondo, Esther
  • Rivero Calle, Irene
  • Mascarós, Enrique
  • Ocaña, Daniel
  • Jimeno, Isabel
  • Gil, Ángel
  • Díaz Maroto, José Luis
  • Linares, Manuel
  • Onieva García, María Ángeles
  • González Romo, Fernando
  • Yuste, José
  • Martinón Torres, Federico
In the adult population, community-acquired pneumonia (CAP) is a serious disease that is responsible for high morbidity and mortality rates, being frequently associated with multidrug resistant pathogens. The aim of this review is to update a practical immunization prevention guideline for CAP in Spain caused by prevalent respiratory pathogens, based on the available scientific evidence through extensive bibliographic review and expert opinion. The emergence of COVID-19 as an additional etiological cause of CAP, together with the rapid changes in the availability of vaccines and recommendations against SARS-CoV-2, justifies the need for an update. In addition, new conjugate vaccines of broader spectrum against pneumococcus, existing vaccines targeting influenza and pertussis or upcoming vaccines against respiratory syncytial virus (RSV) will be very useful prophylactic tools to diminish the burden of CAP and all of its derived complications. In this manuscript, we provide practical recommendations for adult vaccination against the pathogens mentioned above, including their contribution against antibiotic resistance. This guide is intended for the individual perspective of protection and not for vaccination policies, as we do not pretend to interfere with the official recommendations of any country. The use of vaccines is a realistic approach to fight these infections and ameliorate the impact of antimicrobial resistance. All of the recently available scientific evidence included in this review gives support to the indications established in this practical guide to reinforce the dissemination and implementation of these recommendations in routine clinical practice.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Control of microbial agents by functionalization of commercial air filters with metal oxide particles

  • Ribeiro, Bruno
  • Vázquez López, Antonio
  • Vázquez Pufleau, Miguel
  • Llamosí, Mirella
  • Sempere, Julio
  • Yuste, Jose
  • Domenech Lucas, Miriam
  • Wang, De-Yi
  • Vilatela, Juan José
  • Llorca, Javier
  • Echeverry Rendón, Mónica
According to the World Health Organization, low-quality air results in 3.2 million premature annual deaths of which 21 % are attributed to respiratory infections. The recent coronavirus (COVID-19) pandemic, responsible for millions of deaths worldwide, has highlighted the issue of airborne pathogens on human health. Air filtration is an established method to ensure good indoor air quality, being effective at capturing airborne particles and dust, as well as pathogens, and preventing diseases such as asthma. Nevertheless, with usage, water from air humidity, dust, and dirt, including fungi and bacteria spores, can accumulate on filters creating ideal conditions for the propagation of microorganisms. Thus, the filter can become a secondary source for airborne pathogens. In this work, antiviral and antibacterial filters were prepared by spray coating Ag2O, CuO, and ZnO particles into commercially available air filters. The reliability of the filters was tested through particle release in air, through a scanning mobility particle sizer, and filtration performance was measured against an aerosol of iron nanoparticles in nitrogen gas produced through a spark discharge generator. Additionally, the biosafety of the filters was measured in vitro through cytotoxicity tests against L-929 mouse fibroblast cells. Antibacterial activity was measured in vitro against two clinically relevant pathogens: Streptococcus pneumoniae and Pseudomonas aeruginosa and the anti-viral performance was measured against human respiratory syncytial virus. In general, the results have shown that spray coating is a reliable solution, with no detectable cytotoxicity effects or particle release in the air. After functionalization, both Ag2O and CuO compounds have been shown to have total antiviral activity (over 99 %), while only Ag2O presented a clear antibacterial action. In conclusion, spray coating as post-manufacturing functionalization of air filters can be an efficient and low-cost solution against airborne pathogens.